Continuum Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-945
| Closed | -$76.6K | – | 1601 |
|
|
2025
Q1 | $76.6K | Sell |
945
-631
| -40% | -$51.2K | 0.01% | 571 |
|
|
2024
Q4 | $142K | Sell |
1,576
-31,453
| -95% | -$2.83M | 0.02% | 455 |
|
|
2024
Q3 | $3.2M | Buy |
33,029
+1,433
| +5% | +$139K | 0.41% | 54 |
|
|
2024
Q2 | $2.93M | Buy |
31,596
+5,622
| +22% | +$521K | 0.42% | 52 |
|
|
2024
Q1 | $2.31M | Buy |
+25,974
| New | +$2.31M | 0.35% | 71 |
|